Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bd8fe3802b2c7af09ea83cb22fdba5e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2018-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09c4a8ef5b13fc018056e448e4338b0e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ee71b617dd757862da360430b3f4b2a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fc160de39c993d1d7d43c053abfa126 |
publicationDate |
2021-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3880206-A1 |
titleOfInvention |
8-cyclopentyl-7-oxo-2-(4-piperazin-1-yl-phenylamino)-7, 8-dihydro-pyrido [2,3-d]pyrimidine-6-carbonitrile and uses thereof in treating proliferative disorders |
abstract |
The novel compound 8-Cyclopentyl-7-oxo-2-(4-piperazin-l-yl-phenylamino)-7,8-dihydro-pyrido[2,3-<i]pyrimidine-6-carbonitrile and pharmaceutically acceptable salts thereof are described as well as methods of their use in the treatment of cellular proliferative disorders including cancer. |
priorityDate |
2018-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |